Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant expression of human mannan-binding lectin.

T Vorup-Jensen1, E S Sørensen, U B Jensen

  • 1Department of Medical Microbiology and Immunology, University of Aarhus, Denmark. vorup@microbiology.au.dk

International Immunopharmacology
|May 19, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Milk osteopontin retains integrin-binding activity after in vitro gastrointestinal transit.

Journal of dairy science·2019
Same author

Lectin complement pathway proteins in healthy individuals.

Clinical and experimental immunology·2016
Same author

Oligomerization of Mannan-binding Lectin Dictates Binding Properties and Complement Activation.

Scandinavian journal of immunology·2016
Same author

Collectin liver 1 and collectin kidney 1 and other complement-associated pattern recognition molecules in systemic lupus erythematosus.

Clinical and experimental immunology·2015
Same author

Osteopontin is highly susceptible to cleavage in bovine milk and the proteolytic fragments bind the αVβ₃-integrin receptor.

Journal of dairy science·2013
Same author

Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components.

Clinical and experimental immunology·2012

Recombinant mannan-binding lectin (MBL) produced in human embryonic kidney cells closely mimics natural MBL. This advancement offers a promising alternative for MBL reconstitution therapy, overcoming limitations of plasma-derived MBL.

Area of Science:

  • Immunology
  • Biochemistry
  • Biotechnology

Background:

  • Mannan-binding lectin (MBL) is crucial for innate immunity, mediating complement deposition on microbes.
  • MBL deficiency is common, linked to recurrent infections and impaired immune complex clearance.
  • Plasma-derived MBL faces challenges like viral contamination and limited production capacity.

Purpose of the Study:

  • To compare recombinant MBL (rMBL) structures produced in different cell lines.
  • To identify a production method yielding rMBL functionally and structurally similar to natural MBL.
  • To establish a viable recombinant source for MBL reconstitution therapy.

Main Methods:

  • Synthesis of rMBL in myeloma, Chinese hamster ovary (CHO), human hepatocyte, and human embryonic kidney (HEK) cells.

Related Experiment Videos

  • Structural and functional characterization of synthesized rMBL variants.
  • Purification using selective carbohydrate affinity chromatography.

    • Main Results:

    • Recombinant MBL produced in HEK cells demonstrated structural and functional similarity to natural MBL.
    • Previous rMBL production methods resulted in proteins differing from the natural form.
    • Selective carbohydrate affinity chromatography enhanced the quality of HEK-derived rMBL.

    Conclusions:

    • Human embryonic kidney cells are a suitable host for producing clinically relevant rMBL.
    • rMBL produced in HEK cells, purified by affinity chromatography, represents a viable alternative to plasma-derived MBL.
    • This study paves the way for improved MBL-based immunotherapies.